Product
OTOV101N+OTOV101C
1 clinical trial
1 indication
Indication
DFNB9Clinical trial
An Investigator Initiated Study Evaluating the Safety, Tolerability, and Efficacy of OTOV101N+OTOV101C Injection in Treating Patients With OTOF Mutation-related DeafnessStatus: Recruiting, Estimated PCD: 2024-12-06